David K. Packham, M medication information .B., B.S., M.D., Henrik S. Rasmussen, M.D., Ph.D., Philip T. Lavin, Ph.D., Mohamed A. El-Shahawy, M.D., M.P.H., Simon D. Roger, M.D., Geoffrey Block, M.D., Wajeh Qunibi, M.D., Pablo Pergola, M.D., Ph.D., and Bhupinder Singh, M.D.: Sodium Zirconium Cyclosilicate in Hyperkalemia Hyperkalemia is a common electrolyte disorder that’s connected with serious cardiac dysrhythmias and increased mortality.1-3 Individuals with renal dysfunction and those with diabetes are in increased risk for hyperkalemia.12-15 The usage of existing polymer resins includes a poor side-impact profile and uncertain efficacy.
The registry was reviewed and approved by the institutional review table at each participating middle. In 3 centers, written or oral informed consent was obtained from the guardian or parent, and in the additional 22 centers, a waiver of the requirement for consent was accepted by the institutional review board. Data were collected by trained research coordinators for all liveborn infants prospectively, including those never admitted to an intensive care unit. Gestational age was determined with the use of the best obstetrical estimate predicated on the date of the last menstrual period, obstetrical variables, prenatal ultrasonography, or all three.